Brevan Howard Capital Management’s Dentsply Sirona XRAY Stock Holding History

Brevan Howard Capital Management’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.7M	Buy	160,524 +50,185	+45%	+$548K	0.01%	793
2026 Q1	$1.28M	Buy	110,339 +21,976	+25%	+$274K	0.01%	776
2025 Q4	$1.01M	Sell	88,363 -17,199	-16%	-$202K	0.01%	761
2025 Q3	$1.34M	Buy	105,562 +85,560	+428%	+$1.24M	0.01%	765
2025 Q2	$318K	Buy	20,002 +1,800	+10%	+$26.9K	﹤0.01%	1518
2025 Q1	$272K	Sell	18,202 -9,126	-33%	-$162K	﹤0.01%	897
2024 Q4	$519K	Sell	27,328 -3,251	-11%	-$68.7K	﹤0.01%	608
2024 Q3	$827K	Sell	30,579 -10,929	-26%	-$279K	0.01%	514
2024 Q2	$1.03M	Buy	+41,508	New	+$1.19M	0.01%	362
2024 Q1	–	Sell	-9,735	Closed	-$346K	–	1394
2023 Q4	$346K	Buy	9,735 +1,135	+13%	+$36K	﹤0.01%	652
2023 Q3	$294K	Buy	+8,600	New	+$327K	﹤0.01%	249

Other funds holding XRAY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Brevan Howard Capital Management's XRAY Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Dentsply Sirona (XRAY) stake by 45% in Q2 2026, buying an estimated $548K and bringing the position to 160,524 shares worth $1.7M. The position accounts for 0.01% of the portfolio, ranked #793.

Brevan Howard Capital Management first reported a position in XRAY in Q3 2023 and has held it in 11 quarters since. 377 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

Brevan Howard Capital Management held 160,524 shares of Dentsply Sirona worth $1.7M as of Q2 2026.
Brevan Howard Capital Management bought 50,185 Dentsply Sirona shares in Q2 2026, an estimated $548K.
Dentsply Sirona made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #793 holding.
Brevan Howard Capital Management first reported a position in Dentsply Sirona in Q3 2023 and has held it in 11 quarters since.
377 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.